BETTERLIFE PHARMA INC. Operating Expense
BETTERLIFE PHARMA INC. (BETRF) reported Operating Expense of CAD 5.00 million for the 12-month period ending 2025-01-31, per its 20-F filed 2025-06-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpense · last filed 2025-06-02
| Period end | Operating Expense 12 month | Operating Expense 12 month as first filed |
|---|---|---|
| 2025-01-31 | 5.00M CAD 20-F · filed 2025-06-02 | |
| 2024-01-31 | 3.24M CAD 20-F · filed 2025-06-02 | |
| 2023-01-31 | 9.46M CAD 20-F · filed 2025-06-02 | |
| 2022-01-31 | 10.21M CAD 20-F · filed 2024-05-30 | |
| 2021-01-31 | 7.92M CAD 20-F/A · filed 2023-06-06 | |
| 2020-01-31 | 9.34M CAD 20-F · filed 2022-06-06 | 18.73M CAD 20-F/A · filed 2020-06-05 |
| 2019-01-31 | 6.90M CAD 20-F/A · filed 2021-06-23 | 6.91M CAD 20-F/A · filed 2020-06-05 |